Abstract: Schizophrenia is a complex mental disorder with genetic and environmental components. Obstetric complications (OCs) are one of the most common environmental risk factors described. However, despite being different in timing and outcome, OCs are usually described as a homogeneous entity. In the present study, we evaluate the presence of different patterns of OCs evaluated with the Lewis-Murray Scale in chronic schizophrenia patients (n = 101) and their association with a crude marker of the intrauterine environment such as weight at birth. OCs related with abnormal fetal growth (p < 0.001) and OCs during gestation (p = 0.003) were associated with lower birth weight. However, difficulties in delivery, complications in pregnancy, and OCs all together (as a set) were not associated with weight at birth. Our results infer that OCs cannot be taken as a homogeneous group. Different patterns of OCs result in different birth weights, which is associated with specific metabolic, cognitive, and brain structure outcomes.
S
chizophrenia is a complex pathology, where psychiatric symptoms such as delusions, hallucinations, avolition, or apathy, are associated with other conditions such as neurologic abnormalities, cognitive impairment, metabolic disturbances, and medical conditions (Kirkpatrick et al., 2013) . The current literature defines its complexity as an interaction between genetic risk and environmental factors (Bernardo et al., 2013) . Although recent research has focused on later environmental factors, such as adverse experiences in childhood and adolescence (Misiak et al., 2017) , initial emphasis was given to perinatal stress. Indeed, the seminal study by Rosanoff and Inman-Kane (1934) described the unsuspected association between neuropsychiatric illnesses (e.g., behavior disorder and schizophrenia) and physical conditions (low birth weight and ponderal index). This line of research was later continued by Pasamanick et al. (1956) , who proposed the concept of "continuum reproductive casualty," which identified different stressful factors leading to a wide range of neuropsychiatric disorders.
Reviews and meta-analyses of obstetric complications and schizophrenia (Cannon et al., 2002; Matheson et al., 2011) have confirmed the importance of early environmental factors in the genesis of psychosis. From neurologic disturbances (Peralta et al., 2011) to clinical symptoms (Gallagher et al., 2014) , early life stressful events have been described to play an extremely important role (Schmitt et al., 2014) .
However, studies include the concept of obstetric complications from different perspectives, as a dichotomous variable (Gallagher et al., 2014) , as an ordinal factor (Peralta et al., 2011) , or considering just a specific complication, such as hypoxia (Fineberg et al., 2013) . In an effort to identify signals of menaces during gestation, weight at birth has been described as an indirect marker of the intrauterine environment, suggesting, for instance, specific patterns of glucose metabolism over time, in early adulthood (Poulsen and Vaag, 2006) or middle age (Hales et al., 1991) .
The aim of our study is to study the relationship between early life stressful events, defined as the occurrence of different patterns of obstetric complications, and a specific marker of fetal environment, such as weight at birth.
METHODS

Subjects
One hundred one patients were included from a multicenter, cross-sectional study of negative symptoms in schizophrenia. The study recruitment dates were between May 2015 and May 2016 in four centers, which included one UK-based clinic at the Cambridgeshire, Peterborough NHS Foundation Trust (Cambridge) and three in Spain, one in Oviedo (Universidad de Oviedo) and two in Barcelona (Hospital del Mar and Hospital Clinic) . This is a continuation of a prior collaboration for the translation and adaptation of the Brief Negative Symptoms Scale (Mane et al., 2014) into Spanish, but all cases included in the present study were newly recruited.
Inclusion criteria were age between 18 and 65 years, ICD-10 criteria for diagnosis of schizophrenia or schizophreniform disorder (World Health Organization, 1996) , and clinical stability (no changes in antipsychotic or antidepressant treatment during the last 8 weeks). Exclusion criteria were history of neurological disease, head injury, IQ below 80, and drug dependence except for nicotine and cannabis. Ethical approval was obtained from all participating centers. All participants provided written informed consent.
Procedures
Sociodemographic and clinical information were obtained from patients, relatives, and medical records. Assessments were performed by specialized psychiatrists.
We used the Lewis-Murray scale to evaluate obstetric complications (Lewis et al., 1989 ) and stratified our sample into three subscales as suggested by Cannon et al. (2002) labor, and bleeding before delivery of threatened abortion). The second one (group B) includes abnormal fetal growth and development (twin delivery, preterm birth week less than 37 weeks, or long-term birth week of more than 42 weeks, weight at birth less than 2500 g, and any important physical abnormality). By last, the third one (group C) is described as difficulties in delivery (which is composed by premature rupture of membranes or prelabor rupture of membranes, duration of delivery more than 36 hours or less than 3 hours, umbilical cord prolapse, complicated cesarean delivery, abnormal fetal presentation, use of forceps, and being in an incubator for more than 4 weeks). We also considered for statistical analysis another two groups: the combination of group A and B (as any obstetric complication during gestation) and another group that comprehended all the obstetric complications. Previous information was gathered from maternal interview, which, despite possible recall bias, has been described as accurate in psychosis (Walshe et al., 2011) .
Data Analysis
The nonpaired Student's t-test, Mann-Whitney's U-test, or the chi-square test was used for comparisons between groups. Significance was defined as p < 0.05 for all statistical tests, and these were performed using SPSS version 17.0 for Windows. General linear model analyses (GLMs) were performed for each significant difference to control for potential confounding factors.
RESULTS
Obstetric complications (OCs) were present in 41 patients (28 males/13 females) of the total sample. Following items from the Murray-Lewis Obstetric Complications Scale for any of the 15 possible OCs, including antepartum, intrapartum, and postpartum events, the characteristics of our sample were as follows: nobody experienced syphilis or rubella (0%); 4% (2 males and 2 females) presented rhesus isoimmunization/Rh incompatibility; 1% (1 male) had preeclampsia (severe and/or leading to early induction or hospitalization); 8% (6 males and 2 females) had bleeding before delivery or threatened abortion; 2% were twin delivery (2 males); 13% (10 males/3 females) were preterm birth (before 37 weeks) or long-term birth (after 42 weeks); 4%
(1 male/3 females) of the total sample had a weight at birth less than 2000 g; 1% (1 male) had any important physical abnormality (i.e., any gross physical abnormality in the newborn; e.g., a structural congenital anomaly); 4% (4 males) experienced premature rupture of membranes; 6% (6 males) presented labor for more than 36 hours or less than 3 hours; 4% (3 males/1 female) of the sample had umbilical cord prolapse; 7% (5 males/2 females) needed cesarean delivery (complicated or emergency); 4% (3 males/1 female) had breech or an abnormal presentation; 9% (3 males/6 females) needed the use of forceps; and finally 6% (4 males/2 females) of the sample required incubator for more than 4 weeks.
Obstetric complications related with complications of pregnancy (group A) were present in 13% (9 males/4 females) of the sample, related with abnormal fetal growth and development (group B) in 18% (13 males/5 females) and related with difficulties in delivery (group C) in 27% (16 males/10 females) of the total sample. If we consider group A and B together as difficulties during gestation, they were present in 27% (19 males/8 females) of the sample. Overall, 42% of the sample presented at least one obstetric complication. Specific data were missing for three subjects, one regarding premature rupture of membranes and the other two regarding the use of forceps.
Groups were similar for age and sex (Tables 1, 2 ). Significant differences were found in weight at birth in the groups related with abnormal fetal growth development (Fig. 1) and in the groups related with difficulties during gestation (Fig. 2) . Meanwhile the groups related with complications of pregnancy (Fig. 3) , with difficulties in delivery (Fig. 4) , and with at least one obstetric complication (Fig. 5) did not reflect any difference. As brain maturation is extremely sensitive to timing during gestation with differences in sex applying to functioning (Anastario et al., 2012; Gallagher et al., 2014) , we included sex as a potential confounding factor. GLM analyses were conducted with the variables found to be statistically significant, with weight at birth as the dependent variable, and sex and the presence of abnormal fetal growth and development factors (as a dichotomous variable) as independent variables. The interaction between abnormal fetal growth and development factors and sex was also included. Weight at birth was associated with the presence of abnormal fetal growth and development factors (p < 0.001), sex (p = 0.037), and the interaction between abnormal fetal growth and development and sex (p = 0.006). When considering difficulties during gestation (with weight at birth as the dependent variable, and sex and difficulties during gestation as independent ones), difficulties during gestation were associated (p = 0.003), as well as the interaction between sex and difficulties during gestation (p = 0.020); however, sex was not associated with weight at birth (p = 0.249).
DISCUSSION
Our results suggest that different patterns of obstetric complications could be playing a role in the complex heterogeneity of patients diagnosed with schizophrenia, as reflected by presenting different weights at birth. Patients who were affected by factors related with abnormal fetal growth and development and patients with difficulties during gestation showed a statistically lower weight at birth. Nevertheless, patients affected by difficulties in delivery showed no difference in birth weight. From a metabolic perspective, our results delve its roots in the developmental origins of health and disease model (Gluckman and Hanson, 2006) , where as stated by David Barker (Hales and Barker, 1992) , difficulties during the whole gestational period promote longlasting consequences in the metabolism of the offspring leading to increased morbidity and early mortality (Barker et al., 1989) . So, difficulties during gestation will promote changes in birth weight suggesting external menaces affecting the normal development of the fetus.
Our approach tries to highlight that not all the obstetric complications exert the same risk in the offspring, as different weights at birth are associated with specific risks for obesity (Ziauddeen et al., 2016 ), brain structure (Haukvik et al., 2014) , or cognition (Torniainen et al., 2013) .
Abnormalities during pregnancy have been related to an increased risk of developing psychiatric disorders (Monfils Gustafsson et al., 2009 ) and associated with vulnerability to disturbances in specific areas such as metabolism (Garcia-Rizo et al., 2015) or cognition (Brown et al., 2009) . Our approach tries to differentiate obstetric complications (Cannon et al., 2002 ) from fetal development, as difficulties in delivery and menaces during gestation determines different birth weights. This finding is particularly relevant to metabolic outcome as a recent study correlated weight at birth with abdominal obesity in treatment-resistant schizophrenia patients (Ziauddeen et al., 2016) , suggesting that weight at birth is a potential marker for metabolic abnormalities in patients diagnosed with schizophrenia. Our results suggest that when using obstetric complications as a whole, single, and homogeneous variable in schizophrenia, different pathophysiological pathways could be grouped together, possibly confounding the results. As previously stated, adversities during the gestational period would promote metabolic changes in the fetus (Hales and Barker, 1992) , whereas difficulties in delivery would promote disturbances in the dopaminergic system (Giannopoulou et al., 2018) . Both obstetric events are related with the later diagnosis of schizophrenia but also associated with later specific outcomes (medical morbidity or cognitive deficits). Notwithstanding, more research is needed to elucidate the complex interplay of OCs in the outcome of persons diagnosed with schizophrenia.
Our results also displayed sex differences, as birth weight was associated with the interaction between sex and obstetric complications related with abnormal fetal growth and development and with the interaction between sex and difficulties during gestation. Similar results were previously found (Anastario et al., 2012) as chronic placental hypoxia was associated with sex differences on cognition.
Our study has several limitations. First, other stressful events in early childhood or adolescence were not recorded, so their potential effects cannot be ruled out. Second, we categorized the patients according to the presence or absence of risk factors grouped into three categories. As such, the presence of those factors did not exclude the presence of other group factors (having obstetric complications in the other two groups studied), so other described events might have affected the results. Finally, the low number of subjects in some of the categories might have biased our results toward a false-negative pattern.
CONCLUSIONS
Our results highlight the impact of different patterns of early life stressful events on the later outcome of patients diagnosed with schizophrenia, suggesting the possibility that obstetric complications might be underlying the extremely heterogeneity described in patients diagnosed with schizophrenia.
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